Page results
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
Education and training videos for Red Cell Network patients
-
This booklet has been written by the Autonomic Unit at The National Hospital for Neurology and Neurosurgery (NHNN). The aim of the booklet is to provide information about the 24-hour ambulatory blood pressure and heart rate (24-hr BP) monitor.
-
Patient information for Red Cell Network patients
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
Having proton beam therapy: information for children aged 5- 8 patient information leaflet
-
UCLH Charity is delighted to announce that the Dangoor Family’s Exilarch’s Foundation has pledged a £1.2m gift to support the next phase of the development of the CAR T programme at University College London Hospitals NHS Foundation Trust (UCLH). The CAR T Speed Release Project aims to reduce the time between extracting patient’s stem cells and injecting re-engineered CAR T cells back into patients with cancer to fight cancer cells.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
File results
-
FOI/2023/0930 - Patient deaths while on waiting list 2018-2023
-
FOI/2023/0931 - Trust surgical and equipment drape usage in theatre departments
-
FOI/2023/0934 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0936 - Policy and Procedure management at Trust
-
FOI/2023/0938 - Trust pain management education provided to staff
-
FOI/2023/0941 - Paediatric audiology services 2023
-
FOI/2023/0943 - Cancellation of planned surgical procedures
-
FOI/2023/0946 - Treatment of rare diseases; Fabry/ Gaucher/ Pompe disease
-
FOI/2023/0948 - Inpatient wards and bed capacity
-
FOI/2023/0954 - Treatment of melanoma/ Renal cell carcinoma/ Oesophageal cancer